AJP - Heart and Circulatory Physiology, Vol 261, Issue 6 1727-H1733, Copyright © 1991 by American Physiological Society

ARTICLES

Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes

B. C. Millar, T. Weis, H. M. Piper, M. Weber, U. Borchard, B. J. McDermott and A. Balasubramaniam
Department of Therapeutics and Pharmacology, Queen's University of Belfast, United Kingdom.

The potency of neuropeptide Y (NPY) to cause negative and positive contractile responses in rat ventricular cardiomyocytes was investigated. In these cells, NPY was found to activate the transient outward K+ current (Ito) and the slow inward Ca2+ current (Isi). As reported before (H. M. Piper, B. C. Millar, and J. R. McDermott, Naunyn Schmiedeberg's Arch. Pharmacol. 340: 333-337, 1989), NPY attenuated the increase in the contractile response induced by isoprenaline (10(-7) M). This effect of NPY could be abolished by 1) the presence of the inhibitor of Ito, 4-aminopyridine (4-AP, 0.5 mM); 2) pretreatment of the cells with pertussis toxin (1 microgram/ml for 6 h); and 3) the presence of the 19-amino acid COOH-terminal fragment of NPY, NPY-(18-36) (10(-6) M). In the absence of isoprenaline, but in the presence of 4-AP, NPY exerted a stimulatory effect on the cardiomyocytes. This effect could be abolished 1) by using the inhibitor of the Isi, verapamil (10(-8) M), but not 2) by pretreatment with pertussis toxin, nor 3) by coincubation with NPY-(18-36). The results indicate that in the rat the antiadrenergic negative contractile effect of NPY results from its action on the Ito. Blockade of this current by 4-AP unmasks a positive contractile effect of NPY that is related to activation of the Isi.

This article has been cited by other articles:

				L. Protas, J. Qu, and R. B. Robinson Neuropeptide Y: Neurotransmitter or Trophic Factor in the Heart? Physiology, October 1, 2003; 18(5): 181 - 185. [Abstract] [Full Text] [PDF]

				D. Bell, A. R. Allen, E. J. Kelso, A. Balasubramaniam, and B. J. McDermott Induction of Hypertrophic Responsiveness of Cardiomyocytes to Neuropeptide Y in Response to Pressure Overload J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 581 - 591. [Abstract] [Full Text] [PDF]

				M. Kanevskij, G. Taimor, M. Schafer, H. M. Piper, and K.-D. Schluter Neuropeptide Y modifies the hypertrophic response of adult ventricular cardiomyocytes to norepinephrine Cardiovasc Res, March 1, 2002; 53(4): 879 - 887. [Abstract] [Full Text] [PDF]

				M. Michalkiewicz, T. Michalkiewicz, D. L. Kreulen, and S. J. McDougall Increased blood pressure responses in neuropeptide Y transgenic rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R417 - R426. [Abstract] [Full Text] [PDF]

				Y. Goldberg, G. Taimor, H. M. Piper, and K.-D. Schluter Intracellular signaling leads to the hypertrophic effect of neuropeptide Y Am J Physiol Cell Physiol, November 1, 1998; 275(5): C1207 - C1215. [Abstract] [Full Text] [PDF]

				M. C. Michel, A. Beck-Sickinger, H. Cox, H. N. Doods, H. Herzog, D. Larhammar, R. Quirion, T. Schwartz, and T. Westfall XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors Pharmacol. Rev., March 1, 1998; 50(1): 143 - 150. [Abstract] [Full Text] [PDF]